bpc-157 fda news 2026 Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the Peptides Under RFK Jr. in
Description
Platelet-rich Plasma Induces Annulus Fibrosus Cell Proliferation and Matrix Production
This potent combination enhances growth hormone secretion, promoting lean muscle growth, fat burning, and improved sleep
It's not your imagination, and you're not alone in noticing this pattern
Importantly, the therapy also included the consequences thereof (i.e., gastrointestinal and/or liver lesions [27,28,29,30,31,32] as well as severe muscle weakness [33,34])
